URACYL-SPIROOXETAN-NUKLEOSIDE

Patent europeic · EP2430035 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2430035
Numer da la dumonda
EP10718207
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
11-05-2010
Publitgà
21-03-2012
Concedì
03-04-2013
Stritgà
24-12-2024
Motiv
Taxa annuala betg pajada
Classas IPC
C07H 19/06 (2006.01)
C07H 19/10 (2006.01)
A61K 31/7072 (2006.01)
Prioritad
EP 09160215 14.05.2009
Dumonda PCT
PCT/EP2010/056438 11.05.2010
Publicaziun PCT
WO2010/130726 18.11.2010
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-12-2024

    Stritgà, taxa betg pajada

    Status of protective title
    Active → Cancelled
    Cancellation date
    24.12.2024
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 24.12.2024

  2. 01-06-2023

    Midada

    Published in Swissreg on 01.06.2023

  3. 03-04-2013

    Concedì

    Published in Swissreg on 03.04.2013

Partidas

Possessur

Janssen Products, L.P.

800/850 Ridgeway Drive, Horsham PA 19044, US

MEDIVIR AB

Medivir AB

Lunastigen 7, 141 44 Huddinge, SE

Inventur

JONCKERS, Tim, Hugo, Maria

B-2650 Edegem, BE

RABOISSON, Pierre, Jean-Marie, Bernard

B-1331 Rosieres, BE

VANDYCK, Koen

B-3583 Paal-Beringen, BE

VAN HOOF, Steven, Maurice, Paula

B-9820 Merelbeke, BE

HU, Lili

B-2800 Mechelen, BE

TAHRI, Abdellah

B-1070 Anderlecht, BE

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.